Experimental analysis reveals distinct optical properties and transitions of new pyridine isomers, indicating potential as organic dyes.
Two new 2-N-phenylamino-5-nitropyridine—4-methyl (2PA5N4MP) and 2-N-phenylamino-5-nitropyridine-6-methyl (2PA5N6MP) isomers were synthesized and comprehensively characterized by single-crystal X-ray diffraction, IR/Raman spectroscopy, UV–Vis absorption, and photoluminescence measurements. DFT and TD-DFT calculations were also carried out to support the experimental results. The X-ray analysis revealed significant structural differences: 2PA5N6MP adopted an almost planar conformation (pyridine–phenyl dihedral ~3°), whereas 2PA5N4MP was markedly twisted (~45°), leading to distinct hydrogen-bonding motifs (N–H⋯N dimers vs. N–H⋯O interactions). These geometric disparities influenced their electronic properties: 2PA5N6MP exhibited a narrower HOMO–LUMO gap (≈2.45 eV) than 2PA5N4MP (≈3.77 eV), which was consistent with a pronounced bathochromic shift in absorption. Both isomers showed broad UV–Vis absorption (200–520 nm), but the 6-methyl derivative featured an additional low-energy charge–transfer band around 460 nm (with a maximum at ~500 nm) compared to ~355 nm in the 4-methyl isomer. Likewise, their photoluminescence spectra differed as follows: 2PA5N4MP emitted in the violet–blue region (bands at ~415 and 450 nm), whereas 2PA5N6MP had an extra orange band peaking at ~560 nm (in addition to a ~450 nm band). The red-shifted 560 nm emission of 2PA5N6MP was attributed to intersystem crossing into triplet states, in line with TD-DFT predictions. Furthermore, both isomers readily formed complexes with Eu3+ ions, and the Eu3+ chelates exhibited the characteristic red f–f emissions (5D0 → 7F transitions ~590–700 nm), demonstrating efficient sensitization of Eu3+ luminescence. Overall, the position of the methyl substituent strongly modulates the compounds’ optical behavior, and these isomers show promise as tunable organic dyes and effective ligands for luminescent lanthanide complexes.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: